Mechanisms of resistance to EGFR inhibit
β
Jonathan B. Cooper; Ezra Eddy Wyssam Cohen
π
Article
π
2009
π
John Wiley and Sons
π
English
β 209 KB
## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositolβ3βkinase/vβAKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression